↗7 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$124KSold on the market
1Companies
Oct 6, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 202616:02 | Oct 5, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Medical Officer | S · Sell | $6.84 | −1,099 | 169,848 | -1% | −$8K | ||
| Sep 11, 202618:35 | Sep 9, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Medical Officer | A · Grant | — | +30,000 | 170,947 | +21% | — | ||
| Sep 4, 202616:03 | Sep 3, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Medical Officer | S · Sell | $11.16 | −1,100 | 140,947 | -1% | −$12K | ||
| Aug 31, 202619:06 | Aug 27, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Medical Officer | S · Sell10b5-1 | $12.01 | −8,222 | 142,047 | -5% | −$99K | ||
| Aug 31, 202619:06 | Aug 27, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Medical Officer | M · Exercise10b5-1 | $1.92 | +5,306 | 150,269 | +4% | $10K | ||
| Aug 19, 202621:00 | Aug 18, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Medical Officer | S · Sell10b5-1 | $12.00 | −429 | 144,963 | -0% | −$5K | ||
| Aug 19, 202621:00 | Aug 18, 2026 | ARTVArtiva Biotherapeutics, Inc. | Chief Medical Officer | M · Exercise10b5-1 | $1.92 | +429 | 145,392 | +0% | $823.68 |